HK1048263A1 - Medicaments that contain xenogenic oligo-or/and polyribonucleotides. - Google Patents

Medicaments that contain xenogenic oligo-or/and polyribonucleotides.

Info

Publication number
HK1048263A1
HK1048263A1 HK03100562A HK03100562A HK1048263A1 HK 1048263 A1 HK1048263 A1 HK 1048263A1 HK 03100562 A HK03100562 A HK 03100562A HK 03100562 A HK03100562 A HK 03100562A HK 1048263 A1 HK1048263 A1 HK 1048263A1
Authority
HK
Hong Kong
Prior art keywords
polyribonucleotides
medicaments
xenogenic oligo
oligo
contain
Prior art date
Application number
HK03100562A
Other languages
English (en)
Inventor
Hugo Seinfeld
Original Assignee
Hugo Seinfeld
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hugo Seinfeld filed Critical Hugo Seinfeld
Publication of HK1048263A1 publication Critical patent/HK1048263A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
HK03100562A 1999-08-27 2003-01-23 Medicaments that contain xenogenic oligo-or/and polyribonucleotides. HK1048263A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19940748A DE19940748A1 (de) 1999-08-27 1999-08-27 Arzneimittel enthaltend xenogene Oligo- oder/und Polyribonukleotide
PCT/EP2000/008279 WO2001015704A1 (de) 1999-08-27 2000-08-24 Arzneimittel enthaltend xenogene oligo- oder/und polyribonukleotide

Publications (1)

Publication Number Publication Date
HK1048263A1 true HK1048263A1 (en) 2003-03-28

Family

ID=7919851

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03100562A HK1048263A1 (en) 1999-08-27 2003-01-23 Medicaments that contain xenogenic oligo-or/and polyribonucleotides.

Country Status (23)

Country Link
US (1) US20060069057A1 (zh)
EP (1) EP1206267B1 (zh)
JP (1) JP2003508442A (zh)
KR (1) KR100840804B1 (zh)
CN (1) CN1177591C (zh)
AT (1) ATE277622T1 (zh)
AU (1) AU774877B2 (zh)
BR (1) BR0013645A (zh)
CA (1) CA2382034A1 (zh)
CZ (1) CZ2002702A3 (zh)
DE (2) DE19940748A1 (zh)
ES (1) ES2230181T3 (zh)
HK (1) HK1048263A1 (zh)
HU (1) HUP0202888A3 (zh)
IL (1) IL148336A (zh)
MX (1) MXPA02001995A (zh)
NO (1) NO20020937D0 (zh)
NZ (1) NZ516943A (zh)
PL (1) PL197393B1 (zh)
PT (1) PT1206267E (zh)
RU (1) RU2270669C2 (zh)
WO (1) WO2001015704A1 (zh)
ZA (1) ZA200201301B (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10131148A1 (de) * 2001-06-28 2003-01-16 I P L Internat Pharmaceutics L Xenogene Oligo- oder/und Polyribonukleotide als Mittel zur Behandlung von malignen Tumoren
CA2798132A1 (en) * 2010-05-14 2011-11-17 Deseret Biologicals, Inc. Formulations of diluted genetic material and methods for making same
WO2012129519A1 (en) 2011-03-23 2012-09-27 Deseret Biologicals, Inc. Formulations of diluted amino acid segments and methods for making same
RU2620069C2 (ru) * 2014-06-26 2017-05-22 Аоварт Гмбх Вещество и способ модуляции пролиферации и дифференцировки регуляторных, стволовых и других соматических клеток

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2547696A1 (de) * 1975-10-24 1977-04-28 Beecham Group Ltd Antivirale substanz, verfahren zu ihrer herstellung und diese substanz enthaltende arzneipraeparate
SE7607496L (sv) * 1976-07-01 1978-01-02 Astra Laekemedel Ab Sett for bekempning av virusinfektioner
DE2824411A1 (de) * 1978-06-03 1979-12-13 Boehringer Sohn Ingelheim Antiviral wirksame t-rna-praeparate
US4924624A (en) * 1987-10-22 1990-05-15 Temple University-Of The Commonwealth System Of Higher Education 2,',5'-phosphorothioate oligoadenylates and plant antiviral uses thereof
US5512668A (en) * 1991-03-06 1996-04-30 Polish Academy Of Sciences Solid phase oligonucleotide synthesis using phospholane intermediates
FR2713487B1 (fr) * 1993-12-09 1996-02-02 Labo Life Solutions de type homéopathique contenant un acide nucléique utilisables notamment dans la prévention ou le traitement de maladies infectieuses ou de maladies impliquant le dysfonctionnement d'un gène.
DE4438918A1 (de) * 1994-11-04 1996-05-09 Hoechst Ag Modifizierte Oligonukleotide, deren Herstellung sowie deren Verwendung
US6353055B1 (en) * 1994-11-18 2002-03-05 Supratek Pharma Inc. Polynucleotide compositions
US5834443A (en) * 1996-05-21 1998-11-10 Masiello; Domenick J. Composition and method for treating herpes simplex

Also Published As

Publication number Publication date
US20060069057A1 (en) 2006-03-30
PT1206267E (pt) 2005-01-31
IL148336A (en) 2005-11-20
HUP0202888A2 (hu) 2002-12-28
DE19940748A1 (de) 2001-03-01
AU774877B2 (en) 2004-07-08
EP1206267A1 (de) 2002-05-22
KR100840804B1 (ko) 2008-06-23
NO20020937L (no) 2002-02-26
RU2002107675A (ru) 2004-01-10
AU2808101A (en) 2001-03-26
PL353881A1 (en) 2003-12-01
ZA200201301B (en) 2002-11-27
CN1371282A (zh) 2002-09-25
RU2270669C2 (ru) 2006-02-27
DE50008024D1 (de) 2004-11-04
ATE277622T1 (de) 2004-10-15
CZ2002702A3 (cs) 2002-07-17
CA2382034A1 (en) 2001-03-08
CN1177591C (zh) 2004-12-01
HUP0202888A3 (en) 2005-11-28
KR20020031596A (ko) 2002-05-02
NO20020937D0 (no) 2002-02-26
PL197393B1 (pl) 2008-03-31
IL148336A0 (en) 2002-09-12
NZ516943A (en) 2003-09-26
JP2003508442A (ja) 2003-03-04
WO2001015704A1 (de) 2001-03-08
ES2230181T3 (es) 2005-05-01
EP1206267B1 (de) 2004-09-29
BR0013645A (pt) 2002-05-07
MXPA02001995A (es) 2002-09-25

Similar Documents

Publication Publication Date Title
MY155218A (en) Small molecules useful in the treatment of inflammatory disease
BG63122B1 (en) Compounds and methods for cancer treatment
BRPI0007487B8 (pt) difenil-uréias substituídas com w-carbóxi-arilas como inibidores de raf cinase
AP2000001942A0 (en) Use of organophosphoric compounds for the therapeutic and preventative treatment of infections.
IL169897A0 (en) Sustituted heterocycles
IL117874A0 (en) Pharmaceutical compositions for inhibiting the growth of viruses and cancers
CA2418167A1 (en) Compositions and methods of preventing or reducing the risk or incidence of skeletal injuries in horses
SE9802937D0 (sv) Novel compounds
PL340467A1 (en) Application of mithrazapin in treating apnoea dissomnia
IL121272A (en) Pharmaceutical compositions comprising adenosine and their use for treating or preventing leukopenia
MXPA03011270A (es) Uso de antagonistas rank para tratar cancer.
IL148336A0 (en) Medicaments that contain xenogenic oligo-or/and polyribonucleotides
PL357179A1 (en) Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid (2-mtdc) and/or physiologically compatible salts for treating and/or preventing cancers
BR0111785A (pt) Composições e métodos para tratamento de candidìase
WO2004054603A3 (en) Use of beta-defensins for treating hiv infections
BR0008677A (pt) Composto de tiazolindolinona, composição farmacêutica, e, métodos papa preparar um composto de tiazolindolinona, e de prevenção/reduçao da severidade dos efeitos colaterais de citotoxicidade epitelial da quimioterapia e/ou terapia de radiação
WO2000047192A3 (de) UBICHINON Qn ZUR BEHANDLUNG VON SCHMERZEN
LV11593A (lv) Dimetikona pielietojums aizcietejumu arstesana
IL126651A (en) Acyl urea compounds for the treatment of coccidioidomycosis in warm-blooded animals
TR200200987T2 (tr) Kanser tedavisine yönelik,ornatılmış pirroller
WO2002076393A3 (en) Antiagionecic, antitumor, chemopreventative agents
MD1473F2 (en) Antiherpetic remedy
ATE397615T1 (de) 6-o-alkyl-2-nor-2-substituierte ketolidderivate
PL367219A1 (en) Xenogenic oligo or/and polyribonucleotides as agents for the treatment of malignant tumours
AU2002354738A1 (en) Xenogenic oligoor/and polyribonucleotides as agents for the treatment of malignant tumours

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20090824